Operator of an online healthcare platform intended to help patients choose doctors and make appointments.
Operator of an online healthcare platform intended to help patients choose doctors and make appointments.
Other Healthcare Technology Systems📍 Levallois-Perret, FranceFounded 2013
Current Valuation
$6.5B
as of 2022-Q1
UNICORN
QL Price
$3.8B
0% vs last round
QuantLogix's current estimate for Doctolib, published 2026-09-27 — in line with the last disclosed round of $3.8B (2026-02).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$3.8B
2026-02
weight 0.64
How this price has held up
No round has priced for Doctolib since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Doctolib, 2026-09-27 (de2f2239a2a779ea).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Doctolib going public?
No. Doctolib is private and has not filed to go public. There is no S-1 on file.
What is Doctolib's valuation in 2026?
Doctolib is valued at $6.5B as of 2022-Q1, set by its Series F ($557.1M, Mar 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Doctolib filed an S-1?
No public S-1 is on file for Doctolib.
How much has Doctolib raised?
Doctolib has raised $1.0B in total, most recently a Series F of $557.1M in Mar 2022.
Is Doctolib publicly traded — can you buy Doctolib stock?
No. Doctolib is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Doctolib on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2013
HQ
Levallois-Perret, France
Employees
3,000
Total Raised
$1.0B
Last Round
Series F — $557.1M (Mar 2022)
IPO Status
private
Fundraising Status
Series F · $557.1M · 4y 6mo ago
privateTotal raised $1.0B
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$557.1M
Mar 2022
—
$6.5B
Talent Signal
Hiring trend
▼ Hiring downtrend
-10% vs 2026-08
Open roles
123
via greenhouse
Product-build share
39%
engineering, research, product, design
Trajectory
tightening
balanced build + GTM — 39% builders vs 61% go-to-market/G&A — scaling both sides.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Business Developer (x/f/m) - France entièreEngineering Director - Health Companion App - Paris (x/f/m)Engineering Manager- Business Performance (x/f/m)Engineering Manager - Observability & Reliability Engineering Obsession (x/f/m)Engineering Manager - Observability & Reliability Engineering Obsession (x/f/m) Engineering Manager Scheduling Team (x/f/m)
Counted from Doctolib's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.